Cafepharma Today

May 16 2025 - Novo CEO to depart as obesity drugmaker’s challenges rise
Novo CEO to depart as obesity drugmaker’s challenges rise
BioMarin expands enzyme expertise with $270M Inozyme buy
Amgen could owe Regeneron more than $400M after defeat in cholesterol drug antitrust suit
Eli Lilly collaborates with Rznomics on hearing loss treatment in $1.3 billion pact
*please scroll down for all the latest news *

Make it like cafepharma, but for different industries. Learn more about CompanyUnderground

Check open job listings in your area
Click here to stay updated on CP happenings

learn about pharmaceutical fraud
learn about the False Claims Act
learn about clinical lab fraud

Current News

submit a press release

Buying Map Pharmaceuticals Ahead Of FDA Decision
Seeking Alpha
Monday, January 30, 2012 - 12:05pm
tags:
FDA, MAP Pharmaceuticals, migraines, Levadex
Vertex Falls as Analyst Cuts Sales Estimates on Hepatitis C Pill
Bloomberg
Monday, January 30, 2012 - 12:04pm
tags:
Vertex Pharmaceuticals, hepatitis C, Incivek
Why Cambrex May Be About to Take Off
Motley Fool
Monday, January 30, 2012 - 11:07am
tags:
Cambrex
Valeant Pulls Ista Pharma Takeout Bid
TheStreet.com
Monday, January 30, 2012 - 10:58am
tags:
Ista, Valeant Pharmaceuticals, M&A
Vertex Pharmaceuticals Inc. Fourth Quarter Earnings Sneak Peek
Yahoo/Wall St Cheat Sheet
Monday, January 30, 2012 - 10:57am
tags:
Vertex, earnings
Forbes Earnings Preview: Merck
Forbes
Monday, January 30, 2012 - 10:36am
tags:
earnings, Merck
Express Scripts Will Make Changes to Lipitor Coverage
WSJ Online
Monday, January 30, 2012 - 10:34am
tags:
Lipitor, Express Scripts, generics, Pfizer
Earnings Preview: Lilly reports on 4Q results Tues
Yahoo/AP
Monday, January 30, 2012 - 10:33am
tags:
earnings, Eli Lilly
Big Pharma donates drugs for neglected diseases
Reuters
Monday, January 30, 2012 - 10:31am
tags:
Big Pharma, Bill Gates, tropical diseases, WHO, AIDS
Teva eyes $2b Indian acquisition - report
Globes, Israel
Sunday, January 29, 2012 - 12:14pm
tags:
Teva Pharmaceuticals, Micro Labs, M&A
5 Pharma Setbacks This Week
Seeking Alpha
Sunday, January 29, 2012 - 12:12pm
tags:
Infinity Pharmaceuticals, saridegib, Columbia Laboratories, Abbott Laboratories, Novartis, Ranbaxy
Proposed Physician Payment Sunshine Act Regulations Leave Many in the Dark
JD Supra
Sunday, January 29, 2012 - 11:56am
tags:
Physician Payment Sunshine Act
Johnson Takes $3 Billion Hit on Hip Recall
New York Times
Sunday, January 29, 2012 - 11:44am
tags:
JNJ, recalls
Arena Pharmaceuticals Has Over A 300% Upside Potential In 2012
Seeking Alpha
Sunday, January 29, 2012 - 11:42am
tags:
Arena Pharmaceuticals, lorcaserin, weight loss, obesity
Celgene Meets on the Top Line, Misses Where It Counts
Motley Fool
Sunday, January 29, 2012 - 11:40am
tags:
Celgene
Dr. Reddy’s Clarifies Media Reports
BusinessWire
Saturday, January 28, 2012 - 12:57pm
tags:
Dr Reddy's, Fondaparinux Sodium, FDA, legal
GenVec Extends Research Collaboration with Global Pharmaceutical Company
Bradenton Herald, FL
Saturday, January 28, 2012 - 12:51pm
tags:
GenVec, Novartis, hearing loss
Celator Pharmaceuticals Receives EMA Orphan Drug Status for CPX-351 in Acute Myeloid Leukemia
Fierce Biotech
Saturday, January 28, 2012 - 12:46pm
tags:
Celator, CPX-351, leukemia, acute myeloid leukemia, orphan drugs
Amylin Gets Its Yes; Now For The Hard Work
Seeking Alpha
Saturday, January 28, 2012 - 12:36pm
tags:
Amylin, Bydureon, diabetes
Teva Recalls 1 Batch Of Treanda Due To Presence Of Glass In Vial
Fox Business
Saturday, January 28, 2012 - 12:20pm
tags:
Treanda, Teva Pharmaceuticals, recalls

Pages

Latest CP Wire Articles

Hermes Intelligence Launches to Redefine Pharma Data Solutions [sponsored]
The Evolution of Medical Sales: What’s Changing in 2025?
FDA Scraps Key Vaccine Meetings—What It Means for Manufacturers
FDA approves Danziten, the first nilotinib treatment for Ph+ CML with no mealtime restrictions
Daily U.S. Flu Cases Expected to Nearly Double from Last Year by Late November, Predicts Novel Mathematical Forecasting Tool
PharmaBlock Receives 2024 ACS CMO Excellence in Green Chemistry Award, Marking a Second Consecutive Year of Recognition
Leading Clinical Research Network Centricity Research Acquires North Carolina-based Lucas Research
First-of-Its-Kind Alzheimer’s Disease Simulation Paves Way for Personalized Treatment: Penn State, Duke University Study
Centricity Research Appoints New CEO, CFO to Support Next Phase of Growth
Sermo Barometer Examines Influencers’ Impact on Patient Perceptions of Weight Loss Medications & Preventative Care Technologies

Latest Pharmagather Articles

Alzheimer's Update: Infectious Agents and Gamma-Secretase Too
In the Pipeline
Obesity Without Metabolic Dysfunction?
In the Pipeline
New Cell Therapy For Resistant Hodgkins Patients
In the Pipeline
Escape From the Lysosome
In the Pipeline
Heavy Water in Your NMR Experiments, And Elsewhere
In the Pipeline
GIPR: Agonists and Antagonists Do the Same Thing, But How
In the Pipeline
Mutant Proteins Classified
In the Pipeline
The Continuing Crisis, Part XIV: The Trumpist Worldview
In the Pipeline
Whole Lotta Snakin' Going On
In the Pipeline

current feelings about your job

Please rate how you feel about your job this moment. 1 = "I hate my job" and 7 = "I love my job"
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Fill in the blank.